Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wei‐Feng Qu
Observed names:
Wei-Feng Qu,
Weifeng Qu
Institutions:
Shanghai Medical College of Fudan University,
Chinese Academy of Medical Sciences & Peking Union Medical College,
Fudan University,
Zhongshan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Chinese Academy of Medical Sciences & Peking Union Medical College,
Fudan University,
Zhongshan Hospital
ORCID:
0000-0001-9611-0607
Observed ORCID:
0000-0001-9611-0607
OpenAlex ID:
A5034980651
CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor
2023
·
Gui-Qi Zhu
, Zheng Tang
, et al.
·
Cell Discovery
·
406
PDF
Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis
2022
·
Renqiang Sun
, Zhiyong Zhang
, et al.
·
Journal of Hepatology
·
205
Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack
2022
·
Yuan Fang
, Weiren Liu
, et al.
·
Hepatology
·
184
Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis
2021
·
Yu-Fu Zhou
, Shu-Shu Song
, et al.
·
Journal for ImmunoTherapy of Cancer
·
71
PDF
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
2023
·
Wei-Feng Qu
, Meng-Xin Tian
, et al.
·
Hepatology International
·
70
PDF
Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma
2025
·
Tianhao Chu
, Guiqi Zhu
, et al.
·
Nature Communications
·
69
PDF
Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study
2022
·
Wei-Feng Qu
, Zhen-Bin Ding
, et al.
·
BJS Open
·
65
PDF
Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
2021
·
Gui‐Qi Zhu
, Wei‐Ren Liu
, et al.
·
Molecular Oncology
·
61
PDF
A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma
2023
·
Xifei Jiang
, Wenjia Deng
, et al.
·
Cell Discovery
·
58
PDF
Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogramming
2024
·
Han Wang
, Fangming Liu
, et al.
·
Experimental Cell Research
·
56
Single-cell and spatial architecture of primary liver cancer
2023
·
Pei-Yun Zhou
, Cheng Zhou
, et al.
·
Communications Biology
·
54
PDF
Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy
2023
·
Jun Gao
, Yuan Fang
, et al.
·
Oncogene
·
53
Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis
2023
·
Yi Wang
, Gui-Qi Zhu
, et al.
·
Journal of Translational Medicine
·
49
PDF
Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma
2019
·
Zheng Tang
, Wei-Ren Liu
, et al.
·
Journal of Cancer
·
49
PDF
Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection
2020
·
Wei-Feng Qu
, Pei-Yun Zhou
, et al.
·
Annals of Translational Medicine
·
47
PDF
Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
2019
·
Meng-Xin Tian
, Wei-Ren Liu
, et al.
·
BMC Medicine
·
46
PDF
Laser-Induced Combinatorial Chemotherapeutic, Chemodynamic, and Photothermal Therapy for Hepatocellular Carcinoma Based on Oxaliplatin-Loaded Metal–Organic Frameworks
2023
·
Run Huang
, Weiren Liu
, et al.
·
ACS Applied Materials & Interfaces
·
34
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells
2025
·
Gui-Qi Zhu
, Zheng Tang
, et al.
·
Signal Transduction and Targeted Therapy
·
25
PDF
Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: ISICC‐applied prediction model
2020
·
Mengxin Tian
, Weiren Liu
, et al.
·
Cancer Science
·
22
PDF
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma
2023
·
Weiren Liu
, Huqiang Wang
, et al.
·
癌症:英文版
·
21
PDF
Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning
2022
·
Wei-Feng Qu
, Meng-Xin Tian
, et al.
·
Frontiers in Oncology
·
21
Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis
2020
·
Wei-Ren Liu
, Meng-Xin Tian
, et al.
·
BMC Cancer
·
21
PDF
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8 + T cell function and inhibiting tumor growth in hepatocellular carcinoma
2025
·
Wei-Feng Qu
, Gui-Qi Zhu
, et al.
·
Science Advances
·
18
PDF
Targeting Deltex E3 Ubiquitin Ligase 2 Inhibits Tumor‐associated Neutrophils and Sensitizes Hepatocellular Carcinoma Cells to Immunotherapy
2024
·
Xiaoling Wu
, Jiafeng Chen
, et al.
·
Advanced Science
·
18
Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection
2020
·
Wei-Ren Liu
, Meng-Xin Tian
, et al.
·
British Journal of Cancer
·
16
PDF
Show more works
View as search
Works count:
43
Citation count:
1,836
H-index:
21
I10-index:
27
Year
Topic
Type